OCT 22, 2021 12:35 PM PDT

Cannabinoid Pain Treatment for Kidney Disease Patients

WRITTEN BY: Kerry Charron

According to a recent review of cannabis in kidney disease symptom management conducted by University of British Columbia researchers, cannabis treatment has the potential to manage symptoms of chronic kidney disease (CKD) and end stage renal disease (ESRD). The review highlighted the effectiveness of cannabis’s effectiveness in managing neuropathic pain that afflicts a majority of patients undergoing renal replacement therapy such as dialysis. The researchers found that using the lowest cannabis dosage possible was effective for pain management and offered a less addictive alternative to opioid pain management options.

Cannabinoid research has been hindered by historical stigma and illegal status, so there is minimal established research on cannabis’s adverse effects and benefits for patients with CKD. Mount Sinai Hospital Nephrologist Dr. Joshua Rein pointed out the importance of knowing the side effect profile of each route of administration in light of mixed evidence highlighting the benefits and potential adverse effects of cannabis. Some studies suggest that there may be an increased risk of heart attacks or stroke for some patients, while some studies may show an increased risk of lung infection. Overall, Dr. Rein recommends that CKD patients with pulmonary and respiratory diseases avoid smoking and instead seek out other options such as topical creams, tinctures, and edibles.

As cannabis treatments for those with CKD become more prevalent, this increased access will potentially reduce opioid dependence. Over 60% of dialysis patients have at least one opioid prescription despite mixed results regarding opioid’s effectiveness in pain reduction. Cannabis is reported to alleviate the pain, nausea and anxiety afflicting CKD patients.

Research on cannabinoids and renal function will continue to explore the roles that CB1 and CB2 receptors play in cannabinoid kidney treatments. Both receptors may be possible therapeutic targets managing renal deterioration due to diabetes. Future research will also explore the properties of different cannabinoids and most appropriate strains for CKD patients.

 

Sources: Canadian Journal of Kidney Health & Disease, Current Opinion in Nephrology and Hypertension

About the Author
  • Kerry Charron writes about medical cannabis research. She has experience working in a Florida cultivation center and has participated in advocacy efforts for medical cannabis.
You May Also Like
JUN 19, 2021
Health & Medicine
Medical Cannabis Impairs Drivers No More Than Common Meds
JUN 19, 2021
Medical Cannabis Impairs Drivers No More Than Common Meds
 Most people wouldn’t think it highly irresponsible to get behind the wheel after having taken a dose of cold ...
JUN 22, 2021
Cannabis Sciences
Report Finds Most First-Time Cannabis Users are Women
JUN 22, 2021
Report Finds Most First-Time Cannabis Users are Women
Chicago-based cannabidiol (CBD) and cannabis-focused market research organization, Brightfield Group, has published a ne ...
JUL 05, 2021
Cannabis Sciences
Long Term CBD Use Linked to Less Pain, Anxiety and Depression
JUL 05, 2021
Long Term CBD Use Linked to Less Pain, Anxiety and Depression
Researchers from Canada have found that long-term use of cannabidiol (CBD) is linked to improved symptoms of pain, anxie ...
JUL 08, 2021
Cannabis Sciences
High-potency Cannabis Impacts Memory, but not Decision-Making
JUL 08, 2021
High-potency Cannabis Impacts Memory, but not Decision-Making
High-potency cannabis products impair memory in various ways, according to new research published in Scientific Rep ...
NOV 08, 2021
Plants & Animals
Landmark Study of Hemp Seed Genetics
NOV 08, 2021
Landmark Study of Hemp Seed Genetics
The largest genetic study of cannabis genomes has revealed important considerations for farmers selecting high quality h ...
NOV 18, 2021
Cannabis Sciences
Is Cannabis Useful for Symptoms of Endometriosis?
NOV 18, 2021
Is Cannabis Useful for Symptoms of Endometriosis?
Endometriosis is a common gynecologic disorder impacting up to 10% of women of reproductive age in the United ...
Loading Comments...